Viviane Angelina de Souza

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 236 citations · Full text

Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors

Viviane Angelina de Souza, Dílmerson de Oliveira, Sérgio Ribeiro Barbosa et al. · PLoS ONE · 2017 · 203 citations · Full text

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 126 citations

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro et al. · RMD Open · 2021 · 74 citations · Full text

Rectus femoris muscle mass evaluation by ultrasound: facilitating sarcopenia diagnosis in pre-dialysis chronic kidney disease stages

Viviane Angelina de Souza, Dílmerson de Oliveira, Eduardo Neumann Cupolilo et al. · Clinics · 2018 · 56 citations · Full text